Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742820 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers
A Phase 1 study, sponsored by Fresenius Medical Care North America.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00742820 is a Phase 1 study that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 46 participants.
The verdict
NCT00742820, a Phase 1 study, has completed, sponsored by Fresenius Medical Care North America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in healthy volunteers with calcium citrate as a positive control.
Interventions
- DRUG Calcium Acetate Oral Solution 667 mg per 5 mL
- DRUG Calcium Acetate 667 mg GelCaps
- DIETARY_SUPPLEMENT Calcium Citrate 950 mg Caplets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00742820
The ClinicalTrials.gov registry entry for NCT00742820 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fresenius Medical Care North America, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Calcium Acetate Oral Solution 667 mg per 5 mL is the first listed.
NCT00742820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00742820 about?
NCT00742820 is a clinical study titled "Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers". To compare the bioequivalence of calcium acetate oral solution vs. calcium acetate gelcaps in healthy volunteers with calcium citrate as a positive control.
What is the current status of trial NCT00742820?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2008-08. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00742820?
The interventions under investigation include: Calcium Acetate Oral Solution 667 mg per 5 mL (DRUG), Calcium Acetate 667 mg GelCaps (DRUG), Calcium Citrate 950 mg Caplets (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00742820?
This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.